Nutex Health, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67079U1088
USD
156.79
27.02 (20.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
479.95
247.65
219.29
18.79
1.59
1.37
0.06
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
479.95
247.65
219.29
18.79
1.59
1.37
0.06
Raw Material Cost
283.69
212.87
205.84
15.32
1.13
1.01
0.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.93
16.32
12.49
6.80
0.34
0.09
0.64
Selling and Distribution Expenses
58.56
36.07
18.03
12.20
3.42
4.23
1.16
Other Expenses
-1.99
-1.63
-1.25
-0.65
0.02
0.07
-0.06
Total Expenditure (Excl Depreciation)
342.24
248.94
223.87
27.81
5.11
6.01
1.89
Operating Profit (PBDIT) excl Other Income
137.7
-1.3
-4.6000000000000005
-9
-3.5
-4.6000000000000005
-1.7999999999999998
Other Income
0.67
-0.40
-0.56
0.52
1.78
0.00
0.00
Operating Profit (PBDIT)
157.35
15.90
8.06
-7.81
-1.50
-4.46
-1.13
Interest
19.93
16.32
12.49
6.80
0.34
0.09
0.64
Exceptional Items
-8.69
-30.48
-402.02
0.64
-3.61
-2.39
-0.34
Gross Profit (PBDT)
196.26
34.77
13.45
3.47
0.45
0.36
-0.67
Depreciation
18.97
17.59
13.20
0.68
0.24
0.18
0.70
Profit Before Tax
109.75
-48.49
-419.65
-14.65
-5.69
-7.12
-2.81
Tax
14.48
-5.07
13.09
-0.98
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
52.18
-45.79
-424.78
-13.67
-5.69
-7.12
-2.81
Extraordinary Items
0.00
0.00
0.00
0.00
-0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
52.18
-45.79
-424.78
-13.67
-5.69
-7.12
-2.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
43.09
2.36
-7.96
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
95.27
-43.42
-432.74
-13.67
-5.69
-7.12
-2.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
146.34
61.45
95.86
75.14
-1.13
1.86
1.23
Earnings per share (EPS)
9.71
-10.39
-100.36
-54.93
-175.8
-294.06
-1469.25
Diluted Earnings per share
9.71
-10.39
-100.36
-54.93
-175.8
-294.06
-1469.25
Operating Profit Margin (Excl OI)
28.69%
-0.52%
-2.09%
-47.98%
-222.03%
-339.63%
-3039.59%
Gross Profit Margin
26.82%
-12.48%
-185.35%
-74.34%
-343.85%
-507.68%
-3514.63%
PAT Margin
10.87%
-18.49%
-193.7%
-72.73%
-358.77%
-520.82%
-4672.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 93.82% vs 12.90% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 319.59% vs 89.97% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 861.35% vs 89.53% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 22.09% vs 30.40% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Nutex Health, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
479.95
18.53
461.42
2,490.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
479.95
18.53
461.42
2,490.12%
Raw Material Cost
283.69
12.49
271.20
2,171.34%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
19.93
0.07
19.86
28,371.43%
Selling and Distribution Expenses
58.56
8.96
49.60
553.57%
Other Expenses
-1.99
0.12
-2.11
-1,758.33%
Total Expenditure (Excl Depreciation)
342.24
22.75
319.49
1,404.35%
Operating Profit (PBDIT) excl Other Income
137.71
-4.22
141.93
3,363.27%
Other Income
0.67
0.00
0.67
Operating Profit (PBDIT)
157.35
-2.70
160.05
5,927.78%
Interest
19.93
0.07
19.86
28,371.43%
Exceptional Items
-8.69
0.00
-8.69
Gross Profit (PBDT)
196.26
6.05
190.21
3,143.97%
Depreciation
18.97
1.51
17.46
1,156.29%
Profit Before Tax
109.75
-4.29
114.04
2,658.28%
Tax
14.48
0.00
14.48
Provisions and contingencies
0
0
0.00
Profit After Tax
52.18
-4.29
56.47
1,316.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
52.18
-4.29
56.47
1,316.32%
Share in Profit of Associates
0
0
0.00
Minority Interest
43.09
0.00
43.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
95.27
-4.29
99.56
2,320.75%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
146.34
12.09
134.25
1,110.42%
Earnings per share (EPS)
9.71
-2.93
12.64
431.40%
Diluted Earnings per share
9.71
-2.93
12.64
431.40%
Operating Profit Margin (Excl OI)
28.69%
-22.75%
0.00
51.44%
Gross Profit Margin
26.82%
-14.98%
0.00
41.80%
PAT Margin
10.87%
-23.15%
0.00
34.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 47.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 93.82% vs 12.90% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 9.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 319.59% vs 89.97% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.67 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 861.35% vs 89.53% in Dec 2023

Annual - Interest
Interest 1.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 22.09% vs 30.40% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.69%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023